|
|
Article: AVANT Atherosclerosis Vaccine Raises HDL Levels, Reduces Atherosclerosis in Vaccinated Animals.
- Article from:
- PR Newswire
- Article date:
- April 19, 1999
CopyrightCOPYRIGHT 1999 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Company Plans to Initiate Human Safety Studies of the Investigational Vaccine
This Summer
NEEDHAM, Mass., April 19 /PRNewswire/ -- A novel vaccine approach shows promise for raising high density lipoprotein (HDL) or "good" cholesterol levels, and preventing atherosclerosis, according to preclinical research presented today by scientists from AVANT Immunotherapeutics (Nasdaq: AVAN). Vaccinated animals demonstrated 35% higher blood HDL cholesterol levels and atherosclerotic lesions were reduced by approximately 40% (p
"We are very pleased with these results, which clearly demonstrate the feasibility of our vaccine approach as a novel strategy for ...